Keywords: Shin Poong Pharma, Lab francasis FB, Joint venture, Production biotech products, ATryn, FVIIa, Thromboembolisms, Hemophilia
Shin Poong and LFB set up joint venture to manufacture biotech products
Article | 11 January 2013
South Korean drugmaker Shin Poong Pharmaceutical (KOSPI: 019170) and France’s Laboratoire francais du Fractionnement et des Biotechnologies (LFB) have ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
